Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis
ABSTRACT Treatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
|
Series: | Arquivos de Neuro-Psiquiatria |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000900588&lng=en&tlng=en |
id |
doaj-5e15a884f0a14733909915b958406105 |
---|---|
record_format |
Article |
spelling |
doaj-5e15a884f0a14733909915b9584061052020-11-25T00:39:11ZengAcademia Brasileira de Neurologia (ABNEURO)Arquivos de Neuro-Psiquiatria1678-422776958859110.1590/0004-282x20180083S0004-282X2018000900588Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosisLuciana Prats BrancoTarso AdoniSamira Luisa Apostolos-PereiraJoseph Bruno Bidin BrooksEber Castro CorreaCarlos Augusto DamascenoAudred Cristina Biondo EboniLeticia FezerPaulo Diniz da GamaMarcus Vinicius Magno GoncalvesSidney GomesAnderson Kuntz GrzesiukMaria Fernanda MendesRogerio Rizo MoralesAndre MunizMonica Fiuza Koncke ParolinMaria Lucia Vellutini PimentelMarlise de Castro RibeiroGutemberg Augusto Cruz dos SantosHenry Koiti SatoSimone Batista ScherpenhuijzenClaudio ScorcineFabio SiquineliNise Alexandra de Carvalho SousaDaniel Lima VarelaTereza Cristina Avila WincklerYara Dadalti FragosoABSTRACT Treatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One of the most feared complications of these MS treatments is progressive multifocal leukoencephalopathy caused by the reactivation of the John Cunningham virus (JCV). Objective: To identify the serologic profile of JCV in patients with MS. Methods: Data on serum antibodies for JCV were obtained using the enzyme-linked immunosorbent assay provided by the STRATIFY-JCV program. Results: A total of 1,501 blood tests were obtained from 1,102 patients with MS. There were 633 patients (57.1%) who were positive for antibodies for JCV and 469 patients who were negative (42.9%). Twenty-three patients became positive after initially having negative JCV antibody status. The rate of seroconversion was 18.5% over 22 months. Conclusion: The JCV serologic profile and seroconversion in Brazilian patients were similar to those described in other countries.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000900588&lng=en&tlng=enmultiple sclerosisleukoencephalopathy, progressive multifocalJC virusnatalizumab |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luciana Prats Branco Tarso Adoni Samira Luisa Apostolos-Pereira Joseph Bruno Bidin Brooks Eber Castro Correa Carlos Augusto Damasceno Audred Cristina Biondo Eboni Leticia Fezer Paulo Diniz da Gama Marcus Vinicius Magno Goncalves Sidney Gomes Anderson Kuntz Grzesiuk Maria Fernanda Mendes Rogerio Rizo Morales Andre Muniz Monica Fiuza Koncke Parolin Maria Lucia Vellutini Pimentel Marlise de Castro Ribeiro Gutemberg Augusto Cruz dos Santos Henry Koiti Sato Simone Batista Scherpenhuijzen Claudio Scorcine Fabio Siquineli Nise Alexandra de Carvalho Sousa Daniel Lima Varela Tereza Cristina Avila Winckler Yara Dadalti Fragoso |
spellingShingle |
Luciana Prats Branco Tarso Adoni Samira Luisa Apostolos-Pereira Joseph Bruno Bidin Brooks Eber Castro Correa Carlos Augusto Damasceno Audred Cristina Biondo Eboni Leticia Fezer Paulo Diniz da Gama Marcus Vinicius Magno Goncalves Sidney Gomes Anderson Kuntz Grzesiuk Maria Fernanda Mendes Rogerio Rizo Morales Andre Muniz Monica Fiuza Koncke Parolin Maria Lucia Vellutini Pimentel Marlise de Castro Ribeiro Gutemberg Augusto Cruz dos Santos Henry Koiti Sato Simone Batista Scherpenhuijzen Claudio Scorcine Fabio Siquineli Nise Alexandra de Carvalho Sousa Daniel Lima Varela Tereza Cristina Avila Winckler Yara Dadalti Fragoso Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis Arquivos de Neuro-Psiquiatria multiple sclerosis leukoencephalopathy, progressive multifocal JC virus natalizumab |
author_facet |
Luciana Prats Branco Tarso Adoni Samira Luisa Apostolos-Pereira Joseph Bruno Bidin Brooks Eber Castro Correa Carlos Augusto Damasceno Audred Cristina Biondo Eboni Leticia Fezer Paulo Diniz da Gama Marcus Vinicius Magno Goncalves Sidney Gomes Anderson Kuntz Grzesiuk Maria Fernanda Mendes Rogerio Rizo Morales Andre Muniz Monica Fiuza Koncke Parolin Maria Lucia Vellutini Pimentel Marlise de Castro Ribeiro Gutemberg Augusto Cruz dos Santos Henry Koiti Sato Simone Batista Scherpenhuijzen Claudio Scorcine Fabio Siquineli Nise Alexandra de Carvalho Sousa Daniel Lima Varela Tereza Cristina Avila Winckler Yara Dadalti Fragoso |
author_sort |
Luciana Prats Branco |
title |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_short |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_full |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_fullStr |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_full_unstemmed |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_sort |
serological profile of john cunningham virus (jcv) in patients with multiple sclerosis |
publisher |
Academia Brasileira de Neurologia (ABNEURO) |
series |
Arquivos de Neuro-Psiquiatria |
issn |
1678-4227 |
description |
ABSTRACT Treatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One of the most feared complications of these MS treatments is progressive multifocal leukoencephalopathy caused by the reactivation of the John Cunningham virus (JCV). Objective: To identify the serologic profile of JCV in patients with MS. Methods: Data on serum antibodies for JCV were obtained using the enzyme-linked immunosorbent assay provided by the STRATIFY-JCV program. Results: A total of 1,501 blood tests were obtained from 1,102 patients with MS. There were 633 patients (57.1%) who were positive for antibodies for JCV and 469 patients who were negative (42.9%). Twenty-three patients became positive after initially having negative JCV antibody status. The rate of seroconversion was 18.5% over 22 months. Conclusion: The JCV serologic profile and seroconversion in Brazilian patients were similar to those described in other countries. |
topic |
multiple sclerosis leukoencephalopathy, progressive multifocal JC virus natalizumab |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000900588&lng=en&tlng=en |
work_keys_str_mv |
AT lucianapratsbranco serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT tarsoadoni serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT samiraluisaapostolospereira serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT josephbrunobidinbrooks serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT ebercastrocorrea serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT carlosaugustodamasceno serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT audredcristinabiondoeboni serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT leticiafezer serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT paulodinizdagama serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT marcusviniciusmagnogoncalves serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT sidneygomes serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT andersonkuntzgrzesiuk serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT mariafernandamendes serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT rogeriorizomorales serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT andremuniz serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT monicafiuzakonckeparolin serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT marialuciavellutinipimentel serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT marlisedecastroribeiro serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT gutembergaugustocruzdossantos serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT henrykoitisato serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT simonebatistascherpenhuijzen serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT claudioscorcine serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT fabiosiquineli serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT nisealexandradecarvalhosousa serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT daniellimavarela serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT terezacristinaavilawinckler serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT yaradadaltifragoso serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis |
_version_ |
1725294801013702656 |